The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
F-Secure Oyj
OMXH:FSECURE
|
FI |
|
Purple Biotech Ltd
NASDAQ:PPBT
|
IL |
|
DFDS A/S
OTC:DFDDF
|
DK |
|
D
|
Dampskibsselskabet Norden A/S
DUS:D69
|
DK |
|
P
|
Peloton Minerals Corp
CNSX:PMC
|
CA |
|
A
|
Andros Pharmaceuticals Co Ltd
TPEX:6917
|
TW |
|
Communication Cable Systems Indonesia Tbk PT
IDX:CCSI
|
ID |
|
Evli Oyj
F:V6O
|
FI |
|
S
|
S & P Syndicate PCL
SET:SNP
|
TH |
|
C
|
Compass Minerals International Inc
SWB:CM8
|
US |
|
M
|
Morixe Hermanos SACI
BCBA:MORI
|
AR |
|
G
|
Gas Plus SpA
F:T9O
|
IT |
|
S
|
Sharc International Systems Inc
OTC:INTWF
|
CA |
|
M
|
Mayu Global Group Bhd
KLSE:MAYU
|
MY |
|
Minor International PCL
OTC:MNILY
|
TH |
|
T
|
Tpcs PCL
SET:TPCS
|
TH |
|
Blender Bites Ltd
F:JL4
|
CA |
|
M
|
McFarlane Lake Mining Ltd
OTC:MLMLF
|
CA |
|
N
|
Nine Energy Service Inc
F:NEJ
|
US |
|
CEMATRIX Corp
TSX:CEMX
|
CA |
|
Aduro Clean Technologies Inc
TSX:ACT
|
CA |
|
N
|
Nice Call PCL
SET:NCP
|
TH |
|
Akasha Wira International Tbk PT
IDX:ADES
|
ID |
|
S
|
SEI Medical PCL
SET:SEI
|
TH |
F-Secure Oyj (FSECURE)’s 12-month stock price forecast through October 2027 has a consensus target of €2.04, implying 43% upside. The forecast is based on price targets from 7 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for FSECURE is 2.04 EUR with a low forecast of 1.717 EUR and a high forecast of 2.415 EUR.
Over the last 3 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 4 years is 7%.
Over the last 3 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 5%.
Over the last 3 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 8 years is 4%.
Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been -11%. The projected CAGR for the next 3 years is 9%.
Over the last 3 years, the compound annual growth rate for Net Income has been -9%. The projected CAGR for the next 3 years is 11%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more